NRP1 and neoplasm: The results revealed that the NRP1 inhibitor suppressed tumor growth (p < 0.001, Figure 7B) and prolonged survival (p = 0.01, Figure 7D) compared with those in the control group of immunocompetent C57BL/6 mice.